Beam Therapeutics Inc. (BEAM) Stock

Beam Therapeutics Inc. (BEAM) is a Healthcare stock trading at $34.12 (as of 2026-06-18), with a market capitalization of $3.04B and a trailing P/E of -60.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Beam Therapeutics Inc. is developing precision genetic medicines and related therapies for patients in the United States, with programs that include candidates for sickle cell disease, beta thalassemia, relapsed/refractory T-cell acute lymphoblastic leukemia, and liver and other disorders such as Glycogen Storage Disease Type Ia and alpha-1 antitrypsin deficiency.

Valuation — source: SEC EDGAR (first-party)
Price$34.12
Market Cap$3.04B
P/E Ratio-60.5
EV / EBITDA-8.0
Price / Book2.56
Price / Sales18.21
DCF Value (model)$-57.22
DCF Upside vs Price-267.7%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$139.74M
Net Margin-57.2%
Return on Equity-5.6%
Debt / Equity0.09
Current Ratio16.99
Revenue Growth (YoY)120.0%
EPS Growth (YoY)-82.3%
FCF Growth (YoY)1.1%
Financial Health — source: SEC EDGAR
Altman Z-Score7.23 (safe)
Valuation vs Sector & Industry
Stock P/E-60.5
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-388.6%
vs Industry-450.4%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderFMR LLC ($296.74M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOJohn Evans
Employees393
CountryUS
IPO Date2020-02-06

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Nuvation Bio Inc. (NUVB)
  • Disc Medicine, Inc. (IRON)
  • Arcus Biosciences, Inc. (RCUS)
  • Mineralys Therapeutics, Inc. (MLYS)
  • Prestige Consumer Healthcare Inc. (PBH)
  • Catalyst Pharmaceuticals, Inc. (CPRX)
  • Supernus Pharmaceuticals, Inc. (SUPN)
  • Edgewise Therapeutics, Inc. (EWTX)
BEAM earnings history · BEAM institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.